Literature DB >> 3726394

Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts.

G H Karam, F M Griffin.   

Abstract

Invasive pulmonary aspergillosis occurs predominantly in individuals who are neutropenic or who have severe defects in cell-mediated immunity. The isolation of Aspergillus from respiratory secretions of normal hosts usually signifies tracheobronchial colonization, not disease. Recent experience with three nonimmunocompromised patients who had invasive pulmonary aspergillosis, each of whom had Aspergillus isolated from respiratory secretions early in his illness, led to a reassessment of the significance of the isolation of Aspergillus from tracheobronchial secretions. Two of 10 nonimmunocompromised, nonleukopenic individuals who had pulmonary infiltrates and whose sputum yielded Aspergillus had invasive pulmonary aspergillosis, whereas two of five individuals who had pulmonary infiltrates and whose bronchial washings grew Aspergillus had invasive disease. These findings indicate that invasive pulmonary aspergillosis should be considered when Aspergillus is isolated from the respiratory secretions of anyone who has pneumonia, regardless of host defense status.

Entities:  

Mesh:

Year:  1986        PMID: 3726394     DOI: 10.1093/clinids/8.3.357

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  17 in total

1.  Invasive pulmonary aspergillosis in non-immunocompromised patients.

Authors:  J L Hovenden; F Nicklason; R A Barnes
Journal:  BMJ       Date:  1991-03-09

2.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Authors:  L B Palmer; H E Greenberg; M J Schiff
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

Review 3.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

4.  Hematogenously acquired Aspergillus vertebral osteomyelitis in seemingly immunocompetent drug addicts.

Authors:  D L Brown; D M Musher; G E Taffet
Journal:  West J Med       Date:  1987-07

Review 5.  Commentary: unusual manifestations of aspergillosis.

Authors:  D W Denning
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

6.  IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity.

Authors:  K D Forsyth; A W Hohmann; A J Martin; J Bradley
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 7.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

8.  Semi-invasive aspergillosis in an immunocompetent patient with Swyer-James-MacLeod Syndrome: a case report.

Authors:  Sara Mst Salgado; Carla A Costa; António A Bugalho; Júlio Anmq Semedo; José C Ribeiro; Luís M Carreiro
Journal:  J Med Case Rep       Date:  2010-05-26

Review 9.  Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.

Authors:  Melisa M Shah; Eric I Hsiao; Carl M Kirsch; Amit Gohil; Supriya Narasimhan; David A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

10.  Catheter-related cutaneous aspergillosis complicated by fungemia and fatal pulmonary infection in an HIV-positive patient with acute lymphocytic leukemia.

Authors:  C Girmenia; R Gastaldi; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.